Transcatheter Aortic Valve Replacement (TAVR) Market Shares, Strategies and Forecasts Worldwide 2017 adds Global Transcatheter Aortic Valve Replacement (TAVR) Market research report of 52 pages on the transcatheter aortic valve replacement industry to the medical devices intelligence collection of its research store.

Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly (aortic stenosis). It is sometimes also called transcatheter aortic valve implantation (TAVI). Aortic valve replacement typically requires open heart surgery, thus it disqualifies patients who are at high risk for the process or are too weak to undergo a surgery.

Complete report on Global Transcatheter Aortic Valve Replacement (TAVR) Market spread across 52 pages providing 3 company profiles and 8 tables and 33 charts is now available at

As a result, the market of heart valve surgical procedures is witnessing a continuous decline as more and more patients requiring valve replacement are at risk for a surgical treatment. This shortcoming of the traditional surgical method has paved way for the popularity and adoption of TAVR. It was first commercially launched in Europe in 2007 and later in the United States. The market for TAVR is regarded to be promising with immense growth opportunities and unmet demand to cater to.

The key factors which are anticipated to drive market growth include ageing population, healthcare expenditure, increasing obese population and gross domestic product apart from increasing prevalence of inoperable aortic stenosis. Some of the noteworthy developments of this industry include advancement in technologies and favorable reimbursement in Europe. However, the industry remains threatened by certain challenges which include regulatory issues, associated high risk and high cost of TAVR devices.

This report offers a comprehensive analysis of the global TAVR market, along with an in-depth study of the TAVR procedures and the regional markets of the US, Europe and Japan. The global TAVR market is dominated by two major players, Edwards Lifesciences and Medtronic which operate in a highly dynamic environment working in the direction of tapping maximum market share. Both the companies in addition to St. Jude Medical have been profiled in the present report highlighting their key financials and business strategies for growth.

Purchase a copy of this research report at

Company Coverage of Transcatheter Aortic Valve Replacement (TAVR) Market Report:

• Edwards lifesciences
• Medtronic
• St. Jude Medical

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables affecting this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Key Topics Covered:

1. Market Overview
2. TAVR Market Analysis
3. Market Dynamics
4. Competitive Landscape
5. Company Profiles
6. Market Outlook

Other Related Reports on TAVR Market (Transcatheter Aortic Valve Replacement):

Global Transcatheter Aortic Valve Replacement (TAVR) Market DataPack (2015-2019) at

Global Transcatheter Mitral Valve Replacement (TMVR) Market: Size & Forecasts (2016-2021): The mitral valve allows the passage to oxygenated blood from lest atrium (LA) to the left ventricle (LV) and prevent the backflow of blood back into the left atrium. Mitral Regurgitation (MR) is a valve disorder where during heart contraction, blood leaks backward through the mitral valve. This reduces the amount of blood pumped through the body, which leads to declining heart function and heart failure, over the time. There are different approaches for replacement surgery, depending upon the type of MR disease. The TMVR market is in very early stage at this moment, with many companies developing their TMVR devices. The commercial TMVR devices are expected to be launched in next 2-3 years. Complete report available at

Browse All Latest Koncept Analytics Market Research Reports at

Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: Market Reports Online
Phone: + 1 888 391 5441

Release ID: 132451